6533b856fe1ef96bd12b1cbf
RESEARCH PRODUCT
Gender medicine and oncology: report and consensus of an ESMO workshop.
Araba A. AdjeiG-p DottoG-p DottoG-p DottoSolange PetersValery E.p.p. LemmensArnaud HocqueletGeorge CoukosChantal CsajkaJohn B. A. G. HaanenMurielle MauerU. DafniU. DafniA. LetschSabine Oertelt-prigioneIneke KlingeAnna Dorothea WagnerJacques FellayJacques FellayValerie CristinaMichel DucreuxMarkus MoehlerBerna C. ÖZdemirBerna C. ÖZdemirThierry Buclinsubject
0301 basic medicineOncologyMalemedicine.medical_specialtypopulation pharmacokinetic analysissuperior survivalDecision MakingMEDLINElymphomaDiseaseclearanceMedical Oncology03 medical and health sciences0302 clinical medicinerituximabInternal medicineNeoplasmsPhysiciansEpidemiologymedicinegendermelanomasexcancerHumansDosingfemale-patientsSex Characteristicsbusiness.industrygender medicineCancerHematologymedicine.diseaseChemotherapy regimenClinical trial030104 developmental biologyTreatment Outcome030220 oncology & carcinogenesisoncologyimpactBody CompositionFemalepharmacologybusinesssex-differencesSex characteristicsdescription
Background: The importance of sex and gender as modulators of disease biology and treatment outcomes is well known in other disciplines of medicine, such as cardiology, but remains an undervalued issue in oncology. Considering the increasing evidence for their relevance, European Society for Medical Oncology decided to address this topic and organized a multidisciplinary workshop in Lausanne, Switzerland, on 30 November and 1 December 2018.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2019-01-01 | Annals of oncology : official journal of the European Society for Medical Oncology |